{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:12:33Z","timestamp":1793142753113,"version":"4.5.0"},"reference-count":80,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am Soc Clin Oncol Educ Book"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:p>Chronic lymphocytic leukemia (CLL) remains an incurable disease, except in rare cases treated with allogeneic stem-cell transplantation or favorable-risk CLL treated with chemoimmunotherapy. Treatment initiation follows the Rai and Binet staging systems, but the International Workshop on Chronic Lymphocytic Leukemia criteria emphasize active disease rather than stage alone. Early treatment in asymptomatic, high-risk patients has not shown an overall survival benefit, even with targeted therapies such as Bruton's tyrosine kinase and BCL2 inhibitors. The watch-and-wait strategy remains standard, although future trials may refine early treatment indications for specific high-risk groups.<\/jats:p>","DOI":"10.1200\/edbk-25-473656","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T15:59:12Z","timestamp":1745510352000},"source":"Crossref","is-referenced-by-count":9,"title":["When and How Long to Treat Chronic Lymphocytic Leukemia?"],"prefix":"10.1200","volume":"45","author":[{"given":"Carsten U.","family":"Niemann","sequence":"first","affiliation":[{"name":"Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Varghese","sequence":"additional","affiliation":[{"name":"Leeds Teaching Hospital NHS Trust, Leeds, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha","family":"Munir","sequence":"additional","affiliation":[{"name":"Leeds Teaching Hospital NHS Trust, Leeds, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellinor","family":"Goergen","sequence":"additional","affiliation":[{"name":"Department I for Internal Medicine and Centre of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Eichhorst","sequence":"additional","affiliation":[{"name":"Department I for Internal Medicine and Centre of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature15395"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17498"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16183229"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-775841"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-09-667675"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01052-8"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04390-6"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-806398"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V46.2.219.219"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2900060103"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199805213382104"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1796.x"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0747-7"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.246"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022564"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00975"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-556399"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61381-5"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)71182-9"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.06.016"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023020974"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00948"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00220-0"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25638"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01210"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2211582"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006949"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00196-7"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-3934"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2005943"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-12-820910"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023020013"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024024631"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37648-w"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-2779"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2023.2212433"},{"key":"e_1_3_3_40_2","doi-asserted-by":"crossref","unstructured":"Sharman J: Acalabrutinib \u00b1 Obinutuzumab vs. Obinutuzumab + Chlorambucil in Treatment-Na\u00efve Chronic Lymphocytic Leukemia: 5-Year Follow-Up of ELEVATE-TN. 2022: EHA Library 357528. EHA annuael meeting 2022 (Abstract) p 666","DOI":"10.1097\/01.HS9.0000845548.49291.01"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023011307"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00293-5"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13499"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25261"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509388"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817073"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00144-4"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30262-2"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1815281"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213093"},{"key":"e_1_3_3_51_2","first-page":"EVIDoa2200006","article-title":"Fixed-duration ibrutinib-venetoclax in patients with chronic lymphocytic leukemia and comorbidities","volume":"1","author":"Kater AP","year":"2022","unstructured":"Kater AP: Fixed-duration ibrutinib-venetoclax in patients with chronic lymphocytic leukemia and comorbidities. N Engl J Med Evid 1:EVIDoa2200006, 2022","journal-title":"N Engl J Med Evid"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2310063"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(24)00172-8"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00452-7"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01485-x"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-02265"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","unstructured":"Brown J Mashima K Fernandes S et al: Mutations detected in real world clinical sequencing during BTK inhibitor treatment in CLL. Res Sq 10.21203\/rs.3.rs-3837426\/v1","DOI":"10.21203\/rs.3.rs-3837426\/v1"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2409804"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2024.0018"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1130617"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-023-01103-1"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.36.9348"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14342"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07394.x"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18427"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00807"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014488"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-160338"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00894"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(21)00307-0"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3163_153"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00455-1"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-02503"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-207452"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-160338"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.313"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.216"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404584"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12887"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1118357109"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2022-0456"}],"container-title":["American Society of Clinical Oncology Educational Book"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/EDBK-25-473656","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T15:59:15Z","timestamp":1745510355000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/EDBK-25-473656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":80,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1200\/EDBK-25-473656"],"URL":"https:\/\/doi.org\/10.1200\/edbk-25-473656","relation":{},"ISSN":["1548-8748","1548-8756"],"issn-type":[{"value":"1548-8748","type":"print"},{"value":"1548-8756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"article-number":"e473656"}}